Quetiapine Fumarate 300 mg/1 (Quetiapine Fumarate TABLET) 300 mg/1

Quetiapine Fumarate 300 mg tablets are an oral medication used to manage certain mental health conditions. This prescription drug is designed to help balance chemicals in the brain, promoting better mental health.

Strength

300 mg/1

Pack Size

60 TABLET in 1 BOTTLE (0054-0223-21)

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Quetiapine Fumarate is commonly used to treat symptoms of schizophrenia and bipolar disorder. It works by affecting the activity of certain natural substances in the brain. People often ask, 'What is Quetiapine Fumarate used for?' It is primarily prescribed for managing psychotic disorders and stabilizing mood swings associated with bipolar disorder.

Side Effects

Common effects of Quetiapine Fumarate may include drowsiness, dizziness, and dry mouth. Some users also report weight gain and mild headaches. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Quetiapine Fumarate should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid alcohol while taking this medication, as it can increase the risk of side effects.

Avoid Interactions

Quetiapine Fumarate may interact with other medications, including antidepressants, antihistamines, and drugs that affect the central nervous system. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Quetiapine Fumarate is primarily used to treat symptoms of schizophrenia and bipolar disorder.

Quetiapine Fumarate is taken orally, typically once daily, as prescribed by a healthcare professional.

Common side effects include drowsiness, dizziness, dry mouth, weight gain, and mild headaches.

Quetiapine Fumarate may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Long-term use of Quetiapine Fumarate should be monitored by a healthcare professional to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.